Valacyclovir
NDC 71335-0630, Valacyclovir, tablet, film coated, from Bryant Ranch Prepack.
- Product NDC
- 71335-0630
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203047
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0630 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALACYCLOVIR HYDROCHLORIDE1 g/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-0630-0 | 71335063000 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-0630-0) |
| 71335-0630-1 | 71335063001 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-0630-1) |
| 71335-0630-2 | 71335063002 | 21 TABLET, FILM COATED in 1 BOTTLE (71335-0630-2) |
| 71335-0630-3 | 71335063003 | 20 TABLET, FILM COATED in 1 BOTTLE (71335-0630-3) |
| 71335-0630-4 | 71335063004 | 4 TABLET, FILM COATED in 1 BOTTLE (71335-0630-4) |
| 71335-0630-5 | 71335063005 | 10 TABLET, FILM COATED in 1 BOTTLE (71335-0630-5) |
| 71335-0630-6 | 71335063006 | 6 TABLET, FILM COATED in 1 BOTTLE (71335-0630-6) |
| 71335-0630-7 | 71335063007 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-0630-7) |
| 71335-0630-8 | 71335063008 | 8 TABLET, FILM COATED in 1 BOTTLE (71335-0630-8) |
| 71335-0630-9 | 71335063009 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-0630-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e5f5223f-569c-40c6-a3c7-381bc61cf8c6
Use it
Look up 71335-0630 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0630 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-0630. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.